We are live on
!
Find out more
FRM
Fox Run Management Portfolio holdings
AUM
$572M
1-Year Est. Return
24.16%
This Fund
S&P 500
This Quarter
Est. Return
+0.14%
1 Year Est. Return
+24.16%
3 Year Est. Return
+44.85%
5 Year Est. Return
+32.84%
10 Year Est. Return
+244.98%
AUM
$150M
AUM Growth
+$20.3M
(+16%)
Cap. Flow
+$15.7M
Cap. Flow
% of AUM
10.5%
Top 10 Holdings %
Top 10 Hldgs %
9.04%
Holding
664
New
292
Increased
44
Reduced
53
Closed
273
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$1.11M |
| 2 |
CELG
Celgene Corp
CELG
|
+$1.11M |
| 3 |
Nike
NKE
|
+$1.03M |
| 4 |
PAY
Verifone Systems Inc
PAY
|
+$959K |
| 5 |
MON
Monsanto Co
MON
|
+$894K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.43M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$2.19M |
| 3 |
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
|
+$1.41M |
| 4 |
Enterprise Products Partners
EPD
|
+$1.02M |
| 5 |
Magna International
MGA
|
+$933K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 14.63% |
| 2 | Healthcare | 14.32% |
| 3 | Technology | 11.92% |
| 4 | Industrials | 11.68% |
| 5 | Financials | 9.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Molina Healthcare
MOH
$11.7B
| $458K | 0.31% |
+7,100
| New | +$422K |
|
|
PPLI
102
People Inc
PPLI
$3.31B
| $457K | 0.31% |
+54,275
| New | +$467K |
|
103
LyondellBasell Industries
LYB
$19.1B
| $454K | 0.3% |
5,300
| – | – |
|
|
RTN
104
DELISTED
Raytheon Company
RTN
| $454K | 0.3% |
3,700
+2,000
| +118% | +$246K |
|
|
ENH
105
DELISTED
Endurance Specialty Holdings Ltd
ENH
| $451K | 0.3% |
+6,900
| New | +$432K |
|
106
Adobe
ADBE
$94.3B
| $450K | 0.3% |
4,800
-500
| -9% | -$43.3K |
|
107
Apollo Global Management
APO
$69.5B
| $449K | 0.3% |
+26,200
| New | +$393K |
|
108
Douglas Emmett
DEI
$2.1B
| $449K | 0.3% |
+14,900
| New | +$422K |
|
109
Visteon
VC
$2.8B
| $446K | 0.3% |
5,600
+1,500
| +37% | +$118K |
|
|
ZAYO
110
DELISTED
Zayo Group Holdings, Inc.
ZAYO
| $446K | 0.3% |
18,400
-8,500
| -32% | -$207K |
|
111
Altria Group
MO
$124B
| $445K | 0.3% |
7,100
-1,100
| -13% | -$66.5K |
|
|
CRAY
112
DELISTED
Cray, Inc.
CRAY
| $444K | 0.3% |
+10,600
| New | +$404K |
|
|
CST
113
DELISTED
CST Brands, Inc.
CST
| $444K | 0.3% |
+11,600
| New | +$426K |
|
114
Travel + Leisure Co
TNL
$4.57B
| $443K | 0.3% |
12,847
+2,879
| +29% | +$91.3K |
|
|
INFN
115
DELISTED
Infinera Corporation Common Stock
INFN
| $442K | 0.3% |
+27,500
| New | +$422K |
|
116
Costco
COST
$417B
| $441K | 0.29% |
+2,800
| New | +$424K |
|
117
Vail Resorts
MTN
$5.27B
| $441K | 0.29% |
+3,300
| New | +$413K |
|
|
EBIX
118
DELISTED
Ebix Inc
EBIX
| $441K | 0.29% |
+10,800
| New | +$377K |
|
|
SPR
119
DELISTED
Spirit AeroSystems
SPR
| $440K | 0.29% |
+9,700
| New | +$442K |
|
|
SPLK
120
DELISTED
Splunk Inc
SPLK
| $435K | 0.29% |
+8,900
| New | +$401K |
|
|
CHL
121
DELISTED
China Mobile Limited
CHL
| $433K | 0.29% |
+7,800
| New | +$421K |
|
|
MDCO
122
DELISTED
Medicines Co
MDCO
| $432K | 0.29% |
+13,600
| New | +$444K |
|
123
Walmart Inc
WMT
$909B
| $431K | 0.29% |
+18,900
| New | +$414K |
|
124
East-West Bancorp
EWBC
$18.4B
| $429K | 0.29% |
+13,200
| New | +$431K |
|
|
EXPR
125
DELISTED
Express, Inc.
EXPR
| $426K | 0.28% |
995
+295
| +42% | +$106K |
|
Similar funds
MAM
NA
EHI
MW
BSG
RI
XI
TWA
Fox Run Management's Q1 2016 Portfolio in Review
As of Q1 2016, Fox Run Management held 664 positions worth $150M, up 16% from $129M the previous quarter. Its ten largest holdings account for 9% of the portfolio.
Fox Run Management deployed $15.7M of net new capital in Q1 2016, opening 292 new positions and adding to 44 existing holdings. Its largest new stake was Regeneron Pharmaceuticals: 2,700 shares worth $973K.
By sector, the portfolio is most concentrated in Consumer Discretionary at 15% of assets, up from 11% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $2.43M trimmed.
- Fox Run Management's largest Q1 2016 buy was Regeneron Pharmaceuticals: 2,700 shares worth $973K.
- Fox Run Management added most to Hologic in Q1 2016, an estimated $823K increase.
- Fox Run Management's biggest Q1 2016 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.43M.
- Fox Run Management fully exited Enterprise Products Partners in Q1 2016, selling an estimated $1.02M.
- Fox Run Management's ten largest holdings make up 9% of its $150M portfolio in Q1 2016.
- Fox Run Management opened 292 new positions and closed 273 in Q1 2016.
- Fox Run Management's portfolio value rose 16% quarter-over-quarter to $150M.
Based on Fox Run Management's 13F filing for Q1 2016, filed 18 Apr 2016.